DAMORA THERAPEUTICS, INC. Other Non-Current Assets
DAMORA THERAPEUTICS, INC. (DMRA) had Other Non-Current Assets of $48.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-10
- 2026-06-30: Other Assets, Noncurrent $48.00K.
- 2026-03-31: Other Assets, Noncurrent $34.00K.
- 2025-12-31: Other Assets, Noncurrent $104.00K; Other Assets, Noncurrent as first filed $0.00.
- 2025-09-30: Other Assets, Noncurrent $837.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $48.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $34.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $104.00K 10-Q · filed 2026-08-10 | $0.00 10-K · filed 2026-03-19 |
| 2025-09-30 | $837.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $542.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $317.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $163.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $2.10M 10-Q · filed 2024-11-01 | |
| 2024-06-30 | $1.99M 8-K · filed 2024-10-07 | |
| 2024-03-31 | $1.71M 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $1.13M 10-K · filed 2025-03-19 | |
| 2023-09-30 | $2.42M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $2.48M 10-Q · filed 2023-07-31 | |
| 2023-03-31 | $2.49M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $2.28M 10-K · filed 2024-03-08 | |
| 2022-09-30 | $2.81M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $3.01M 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $2.80M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $2.03M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $1.36M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.13M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.12M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $1.16M 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |